Second-line Switch to Dolutegravir Study
Condition(s):HIV-1-infectionLast Updated:January 27, 2022Completed
Hide Studies Not Open or Pending
Condition(s):HIV-1-infectionLast Updated:January 27, 2022Completed
Condition(s):HIV InfectionLast Updated:July 2, 2018Completed
Condition(s):HIV InfectionsLast Updated:February 15, 2024Active, not recruiting
Condition(s):HIV-1-infectionLast Updated:January 12, 2024Not yet recruiting
Condition(s):HIV InfectionsLast Updated:November 8, 2022Completed
Condition(s):HIV-1-infectionLast Updated:March 29, 2023Recruiting
Condition(s):Human Immunodeficiency Virus; Dolutegravir; Monotherapy; Treatment EfficacyLast Updated:November 1, 2017Completed
Condition(s):HIV-1 InfectionLast Updated:December 7, 2020Terminated
Condition(s):HIV InfectionsLast Updated:October 21, 2021Completed
Condition(s):HIV; Hepatitis CLast Updated:March 17, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.